Searched for
BNT
'Faster mining nods key to meet '30 aluminium goals'Industry experts emphasize that India needs faster mining approvals and recycling mandates to meet ambitious aluminium production goals for...- Bristol Myers agrees up to $11.1 billion deal with BioNTech to shake up cancer immunotherapyThe deal, which includes $3.5 billion in unconditional payments, underpins BioNTech's ambition to continue a costly long-term focus on expe...
- Third Covid booster linked with 90 per cent reduction in deaths: StudyA third booster dose of a COVID-19 vaccine was associated with a 90 per cent reduction in death in people with multiple health conditions c...
- Oil slips as investors eye EU vote on Russian oil banOil prices slipped in early Asian trade on Monday as investors eyed talks at the European Union on a Russian oil embargo that is expected t...
- AstraZeneca Covid booster shot effective against severe disease, UK study findsThe researchers from the UK Health Security Agency, London, estimated vaccine effectiveness by analysing data on all adults aged 18 years a...
- At least 45 people killed in bus accident in BulgariaAccording to the bTV channel, 12 children were onboard the bus, which was travelling from Turkey's main city of Istanbul to Skopje in North...
- Lancet study says benefits of vaccines more than risk of facial paralysisBell's palsy is the sudden onset of one-sided facial paralysis.
- Our vaccine highly effective on COVID-19 variant prevalent in India, suitable for 12 years and above: Pfizer to GovtPfizer, which is ready to offer 5 crore doses to India between July and October this year and has sought certain relaxations including inde...
- Pfizer-BioNTech COVID-19 vaccine protection lasts at least 'six months', protects against variantsOn Wednesday, the companies said a small trial of volunteers aged 12 to 15 showed 100 per cent efficacy in that age group.
- Pfizer vaccine appears effective against coronavirus variant found in Britain: StudyThe encouraging results from an analysis of blood of participants in trials are based on more extensive analysis than those released by the...
- Pfizer-BioNTech vaccine documents hacked in EU cyberattackThe Dutch national police high-tech crime team was involved in the probe into the cyberattack, but police gave no more information, the Dut...
- Rupee settles 8 paise lower against US dollarThe dollar index, which gauges the greenback's strength against a basket of six currencies, rose 0.33 per cent to 92.62.
- Pfizer shares surge nearly 4% on vaccine reportGlobal drugmakers Pfizer and BioNTech said on Wednesday that their COVID-19 vaccine was found 95 per cent effective in the final analysis o...
- Rupee slips 13 paise to 74.32 against US dollar in early tradeOn Wednesday, rupee had settled at 74.19 against the US dollar.
- EU reviewing Pfizer-BioNTech COVID-19 vaccine in real timePfizer and BioNTech said in a joint statement the start of the review is based on data from laboratory and animal testing, as well as early...
- Pfizer-BioNTech vaccine candidate induces immune response in early-phase clinical trial: StudyAccording to the study the vaccine candidate is delivered intramuscularly, and enables human cells to produce proteins part of the SARS-CoV...
- Pfizer, BioNTech's coronavirus vaccine candidates get FDA's 'fast track' statusTwo experimental coronavirus vaccines jointly developed by German biotech firm BioNTech and U.S. pharmaceutical giant Pfizer have received ...
- BioNTech and Pfizer's COVID-19 vaccine shows potential in human trialThe drug is one of 17 being tested on humans in a frantic global race to find a vaccine the world is counting on to end a pandemic that has...
- German company begins testing possible vaccineBioNTech said in a statement that in a next step, it will begin increasing the dose of BNT162 in a trial involving about 200 participants a...
- Goldseat ties up with BNT Motors for on-board entertainmentSet up in 2016, GoldSeat is a licensed on-the-go offline entertainment application for premium travel services across air, bus and railway ...
Load More
